Indian techie appointed VP of US pharma major | india | Hindustan Times
  • Monday, Jul 16, 2018
  •   °C  
Today in New Delhi, India
Jul 16, 2018-Monday
-°C
New Delhi
  • Humidity
    -
  • Wind
    -

Indian techie appointed VP of US pharma major

Indian-origin management expert Vikas Sinha has been appointed as senior vice president and chief financial officer of Connecticut-based Alexion Pharmaceuticals, Inc.

india Updated: Sep 03, 2005 13:30 IST

An Indian-origin management expert, who has worked with international chemicals and healthcare group Bayer AG for more than 10 years, has been appointed as senior vice president and chief financial officer of Connecticut-based Alexion Pharmaceuticals, Inc.

The pharma company announced on Friday its appointment of Vikas Sinha to the two positions.

Sinha, 42, was earlier vice president and chief financial officer of Bayer AG's Bayer Pharmaceuticals Corporation, USA.

At Alexion, he will be responsible for all areas of Alexion's finance, accounting, information systems and administration.

"I welcome Vikas to the Alexion management team and look forward to working closely with him as the company continues to transition from a development-stage research organisation to one that is commercially focused," said Leonard Bell, MD, chief executive officer.

"In particular, Vikas' deep and broad commercial expertise will be important building blocks for the company as we progress our product candidates, eculizumab and pexelixumab, into the marketplace."

Alexion focuses on developing therapeutic products aimed at treating patients with a wide array of severe disease states, including hematologic and cardiovascular disorders, auto-immune diseases and cancer. The company's two lead products pexelizumab and eculizumab, are currently undergoing evaluation in several clinical development programmes.

Sinha was with Bayer AG since June, 1994, starting in Toronto, Canada, holding various positions within the company in the US, Japan, Germany and Canada.

As vice president and chief financial officer of Bayer Pharmaceuticals Corporation, US, since February 2001 he was responsible for financial and business risk management, strategic planning, contracting, customer services, information systems, supply chain and site administration in North America. He was also a member of the Pharmaceutical Management Committee for North America.

Prior to his appointment in the US, he was vice president and chief financial officer of Bayer Yakuhin Ltd., in Japan and manager, mergers and acquisitions with Bayer AG in Germany.

Before he joined Bayer, Sinha held several positions with ANZ Bank and Citibank in South Asia.

He holds a Masters of Business Administration from the Asian Institute of Management, which includes an exchange programme with the University of Western Ontario (Richard Ivey School of Business). He is also a qualified chartered accountant from the Institute of Chartered Accountants of India.